“Although some disease sequelae are long-standing in nature, many disease sequelae will be removed when controlling inflammation,” he emphasized, saying that clinicians should “try to overcome the inflammation as soon as possible in order to prevent possible long-term imprinting of disease sequelae due to structural changes in involved organs.”
You Might Also Like
- Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting
- 2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease
- 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists
Explore This IssueMarch 2014
Also By This Author
Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.
- Straub RH. Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology. J Mol Med. 2012;90:523-534.
- Straub RH, Cutolo M, Buttgereit F, Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010;267:543-560.
- Straub RH, Besedovsky HO. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J. 2003;17:2176-2183.